Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;35(6):1574-1586.
doi: 10.1038/s41433-021-01421-4. Epub 2021 Feb 12.

Headache for ophthalmologists: current advances in headache understanding and management

Susan P Mollan  1 , Jasvir S Virdee  1 , Edward J Bilton  1 , Mark Thaller  2 , Anita Krishan  3 , Alexandra J Sinclair  4   5
Affiliations
Review

Headache for ophthalmologists: current advances in headache understanding and management

Susan P Mollan et al. Eye (Lond). 2021 Jun.

Abstract
in English, Chinese

Patients with headache and head pain are often referred to ophthalmologists. These symptoms can either be associated with underlying ophthalmic conditions, or more often are headache disorders unrelated to the eyes. Understanding the phenotype of the headache is critical for advice, safe discharge or onward referral. This review will provide an update on the criteria for common headache disorders that are often seen by ophthalmology and embrace disorders associated with ophthalmic diseases. It will also describe the changing management of migraine and outline recent therapies that are currently available.

摘要: 令眼科医生头痛的难题: 目前对头痛的认识以及相关治疗的最新进展摘要有头疼和头部不适的病人通常会被建议看眼科医生。这些症状可能与潜在的眼科疾病有关, 或者更常见的是与眼科无关的头部疾病。了解头痛的分型对于患者的诊治建议、安全出院或随后的转诊都至关重要。这篇综述将对眼科常见的头痛疾病的标准进行更新, 其中包括与眼科疾病相关的头痛疾病。本文也描述了针对偏头痛进行诊治管理的变化, 并概述目前可用的最新疗法。.

PubMed Disclaimer

Conflict of interest statement

SPM—Novartis, speaker fees (2020). Invex therapeutics, advisory board (2020). ASJ—Novartis and Allergan Advisory board. Speaker fees Novartis. Invex therapeutics, company director with salary and stock options (2019, 2020). No other authors contributing have a conflict of interest in the subject matter.

References

    1. WHO. Headache Disorders 2016. [Internet]. World Health Organisation. [updated 8 April 2016; cited 24 May 2020]. https://www.who.int/en/news-room/fact-sheets/detail/headache-disorders.
    1. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Neurology. 2008;7:354–61. - PubMed
    1. WHO. Atlas of headache disorders and resources in the world 2011. [Internet]. World Health Organisation. [updated 2011; cited 24 May 2020]. https://www.who.int/mental_health/management/atlas_headache_disorders/en/.
    1. Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459–80. - PMC - PubMed
    1. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population. Neurology. 2008;71:559–66. - PubMed